Nurix Therapeutics Inc.
(NRIX)
undefined
undefined%
At close: undefined
20.27
0.30%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 76.99M | 38.63M | 29.75M | 17.82M | 31.11M | 37.45M |
Cost of Revenue | 189.15M | 10.81M | 6.08M | 66.49M | 45.02M | 40.51M |
Gross Profit | -112.16M | 27.82M | 23.67M | -48.67M | -13.91M | -3.06M |
Operating Income | -155.06M | -183.87M | -117.89M | -64.98M | -22.24M | -9.74M |
Interest Income | 11.12M | 3.51M | 823.00K | 1.21M | 776.00K | 818.00K |
Pretax Income | -143.95M | -180.36M | -117.06M | -63.78M | -21.46M | -8.92M |
Net Income | -143.95M | -166.04M | -117.19M | -43.24M | -21.70M | -9.43M |
Selling & General & Admin | 42.90M | 38.00M | 31.20M | 16.31M | 8.33M | 6.67M |
Research & Development | 189.15M | 184.50M | 116.43M | 66.49M | 45.02M | 40.51M |
Other Expenses | - | - | - | - | - | - |
Operating Expenses | 232.05M | 222.49M | 147.64M | 82.80M | 53.35M | 47.19M |
Interest Expense | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 232.05M | 222.49M | 147.64M | 82.80M | 53.35M | 47.19M |
Income Tax | - | -14.31M | 131.00K | -20.54M | 239.00K | 507.00K |
Shares Outstanding (Basic) | 54.34M | 48.61M | 42.90M | 15.67M | 38.85M | 16.11M |
Shares Outstanding (Diluted) | 54.34M | 48.61M | 42.90M | 15.67M | 38.85M | 16.11M |
EPS (Basic) | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
EPS (Diluted) | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
EBITDA | -141.41M | -173.06M | -111.80M | -62.80M | -19.88M | -6.75M |
Depreciation & Amortization | 13.65M | 10.81M | 6.08M | 2.18M | 2.35M | 2.99M |